Αρχική / Ερευνητικό Έργο / Ερευνητικά Πρωτόκολλα

Ερευνητικά Πρωτόκολλα

Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.

Diakatou E, Alexandraki KI, Tsolakis AV, Kontogeorgos G, Chatzellis E, Leonti A, Kaltsas GA.
Clin Endocrinol (Oxf). 2015 Sep;83(3):420-8. doi: 10.1111/cen.12775. Epub 2015 Apr 24.

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role.

Kanakis G, Grimelius L, Spathis A, Tringidou R, Rassidakis GZ, Öberg K, Kaltsas G, Tsolakis AV.
Neuroendocrinology. 2015;101(3):211-22. doi: 10.1159/000381061. Epub 2015 Feb 26.

Somatostatin and dopamine receptor profile of gastroenteropancreatic neuroendocrine tumors: an immunohistochemical study.

Diakatou E, Kaltsas G, Tzivras M, Kanakis G, Papaliodi E, Kontogeorgos G.
Endocr Pathol. 2011 Mar;22(1):24-30. doi: 10.1007/s12022-011-9149-8.

Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance.

Kaltsas GA, Cunningham JL, Falkmer SE, Grimelius L, Tsolakis AV.
Endocr Relat Cancer. 2010 Dec 13;18(1):61-71. doi: 10.1677/ERC-10-0026. Print 2011 Feb.

Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.

Alexandraki KI, Kaltsas GA, le Roux CW, Fassnacht M, Ajodha S, Christ-Crain M, Akker SA, Drake WM, Edwards R, Allolio B, Grossman AB.
Clin Endocrinol (Oxf). 2010 Mar;72(3):305-11. doi: 10.1111/j.1365-2265.2009.03631.x. Epub 2009 May 16.

High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas.

Piaditis GP, Kaltsas GA, Androulakis II, Gouli A, Makras P, Papadogias D, Dimitriou K, Ragkou D, Markou A, Vamvakidis K, Zografos G, Chrousos G.
Clin Endocrinol (Oxf). 2009 Dec;71(6):772-8. doi: 10.1111/j.1365-2265.2009.03551.x. Epub 2009 Feb 18.